Age-Related Neurodegeneration and Memory Loss in Down Syndrome
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Down syndrome (DS) is a condition where a complete or segmental chromosome 21 trisomy causes variable intellectual disability, and progressive memory loss and neurodegeneration with age. Many research groups have examined development of the brain in DS individuals, but studies on age-related changes should also be considered, with the increased lifespan observed in DS. DS leads to pathological hallmarks of Alzheimer's disease (AD) by 40 or 50 years of age. Progressive age-related memory deficits occurring in both AD and in DS have been connected to degeneration of several neuronal populations, but mechanisms are not fully elucidated. Inflammation and oxidative stress are early events in DS pathology, and focusing on these pathways may lead to development of successful intervention strategies for AD associated with DS. Here we discuss recent findings and potential treatment avenues regarding development of AD neuropathology and memory loss in DS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 1×
“A marker of RNA oxidative damage, 8-hydroxyguanosine (8-OHG), is elevated in neurons of the hippocampus and cortex early in the progression of AD and precedes much of the pathology in these regions, suggesting that oxidative stress may be the earliest event in AD-related disease processes [124].”
BackgroundA mouse model for Down syndrome exhibits learning and behaviour deficits
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913 · cited 1×
“Ts65Dn mice show consistent learning and memory deficits on spatial reference and working memory tasks [56, 61–67].”
BackgroundDe Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882
The pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812 · cited 1×
“Progressive age-related memory deficits occurring in both AD and in DS have been connected to degeneration of several neuronal populations, but mechanisms are not fully elucidated.”
BackgroundChromosome 21 and Down syndrome: from genomics to pathophysiology
Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703 · cited 2×
“More importantly, these mice exhibit normal lifespans, allowing for the analysis of progressive neurodegenerative alterations.”
BackgroundWoolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L., & Rankin, K. P. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06382oli · Cited by 549 · cited 1×
“The most common cause of dementia is Alzheimer’s disease (AD), with rates of prevalence increasing steadily from 60 years of age to reach almost 40% by the age of 85 [1].”
BackgroundBerchtold, N. C., Chinn, G., Chou, M., Kesslak, J. P., & Cotman, C. W. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.026 · Cited by 471
Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448
The neuropathology of aminergic nuclei in Alzheimer's disease
Zweig, R. M., Ross, C. A., Hedreen, J. C., Steele, C., Cardillo, J. E., Whitehouse, P. J., Folstein, M. F., & Price, D. L. (1988) · Annals of Neurology · doi:10.1002/ana.410240210 · Cited by 446
Grudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396 · cited 1×
“Cortical neuronal loss is preceded by degeneration of certain subcortical neuronal populations, including basal forebrain cholinergic neurons (BFCNs) [3] and noradrenergic neurons of the locus coeruleus (LC-NE) [4, 5].”
Background
Research works printed but not linked: 108
- 2010, Advances in Experimental Medicine and Biology, 685, 34, 10.1007/978-1-4419-6448-9_4 · DOI
- 10.1016/j.bbr.2010.11.058 · DOI · Paper page
- 10.1111/j.1440-1789.2006.00725.x · DOI · Paper page
- 10.1007/s00401-009-0521-4 · DOI
- 10.1371/journal.pone.0010659 · DOI · Paper page
- 10.1016/S1474-4422(10)70112-5 · DOI · Paper page
- 1996, Nature Medicine, 2, 93, 10.1038/nm0196-93 · DOI · Paper page
- 10.1001/archneurol.2011.104 · DOI · Paper page
- 10.1136/jnnp.2006.113514 · DOI · Paper page
- 10.1016/j.cbi.2009.11.018 · DOI
- 10.2174/156720507780362164 · DOI · Paper page
- 2009, Cochrane Database of Systematic Reviews
- 2009, Cochrane Database of Systematic Reviews
- 10.1002/ajmg.a.32581 · DOI
- 10.1002/gcc.20764 · DOI
- 1982, National Cancer Institute Monograph, 60, 241
- 10.3233/JAD-2010-101218 · DOI · Paper page
- 10.1002/gps.502 · DOI · Paper page
- 10.1002/gps.1077 · DOI · Paper page
- 10.1002/mrdd.1025 · DOI · Paper page
- 10.2353/ajpath.2008.071053 · DOI · Paper page
- 2000, American Journal of Pathology, 157, 277, 10.1016/S0002-9440(10)64538-5 · DOI · Paper page
- 10.1007/s00415-002-0799-9 · DOI
- 10.1016/S0896-6273(02)00604-9 · DOI · Paper page
- 10.3233/JAD-2010-1219 · DOI · Paper page
- 10.1016/j.mrfmmm.2009.08.016 · DOI
- 10.1093/hmg/ddl211 · DOI · Paper page
- 10.1111/j.1460-9568.2004.03188.x · DOI · Paper page
- 10.2174/156720506779025305 · DOI · Paper page
- 1990, Progress in Clinical and Biological Research, 360, 263
- 10.1016/S0378-1119(03)00769-8 · DOI · Paper page
- 10.1016/j.neuron.2006.05.022 · DOI · Paper page
- 10.1016/j.neurobiolaging.2003.10.010 · DOI
- 10.3727/096368910X528085 · DOI · Paper page
- 10.1016/j.brainres.2009.08.052 · DOI
- 10.1002/ana.20250 · DOI · Paper page
- 10.1016/j.biopsych.2009.08.018 · DOI
- 10.1016/S0168-0102(03)00005-1 · DOI
- 10.1016/j.expneurol.2004.11.017 · DOI
- 10.1016/S0166-4328(02)00082-7 · DOI
- 10.1006/exnr.1999.7289 · DOI · Paper page
- 10.1126/scitranslmed.3000258 · DOI · Paper page
- 10.1016/S0166-4328(02)00275-9 · DOI
- 10.1523/JNEUROSCI.1547-09.2009 · DOI · Paper page
- 10.1093/hmg/ddm022 · DOI · Paper page
- 10.1016/S0166-2236(02)02037-4 · DOI · Paper page
- 10.1016/j.clinph.2006.07.134 · DOI
- 10.1038/nn1860 · DOI · Paper page
- 10.1016/S0166-4328(97)00116-2 · DOI
- 10.1016/S0926-6410(00)00074-4 · DOI
- 10.1016/j.nbd.2011.04.011 · DOI · Paper page
- 10.1016/j.nlm.2007.05.007 · DOI
- 10.1159/000330861 · DOI · Paper page
- 10.1038/sj.npp.1301535 · DOI · Paper page
- 10.1016/j.bbr.2010.03.036 · DOI · Paper page
- 10.3233/JAD-2010-100240 · DOI · Paper page
- 10.1046/j.1365-2788.2000.00305.x · DOI · Paper page
- 10.2174/156720508784533286 · DOI · Paper page
- 2002, Journal of Neuroscience, 22, 2434, 10.1523/JNEUROSCI.22-07-02434.2002 · DOI · Paper page
- 10.1073/pnas.0909586107 · DOI · Paper page
- 10.1016/j.neuint.2010.02.001 · DOI
- 10.1124/mol.104.007864 · DOI
- 10.1016/S0306-4522(97)00546-0 · DOI
- 10.1016/S0079-6123(07)63018-0 · DOI
- 10.1016/j.neurobiolaging.2006.06.003 · DOI · Paper page
- 10.1002/cne.20744 · DOI · Paper page
- 10.1002/ana.410320510 · DOI · Paper page
- 1983, Clinical Neuropathology, 2, 1
- 10.1001/archneur.60.3.337 · DOI · Paper page
- 10.5414/NPP30104 · DOI
- 10.1002/mds.22307 · DOI · Paper page
- 10.1097/JGP.0b013e3181aad585 · DOI
- 10.1345/aph.1P341 · DOI · Paper page
- 10.1016/j.neurobiolaging.2004.05.010 · DOI · Paper page
- 1997, Acta Neurologica Scandinavica, 96, 236
- 10.1016/j.bcp.2005.05.019 · DOI
- 10.1016/S0169-328X(03)00092-5 · DOI
- 10.2174/187152707783399193 · DOI · Paper page
- 1986, Neurobiology of Aging, 7, 297, 10.1016/0197-4580(86)90010-2 · DOI
- 1989, Progress in Clinical and Biological Research, 317, 353
- 10.1016/S0197-0186(02)00049-9 · DOI · Paper page
- 10.1111/j.1601-183X.2007.00378.x · DOI · Paper page
- 2004, Progress in Brain Research, 146, 3
- 2005, Journal of Neuropathology and Experimental Neurology, 64, 263, 10.1093/jnen/64.4.263 · DOI · Paper page
- 10.1016/j.pneurobio.2006.09.001 · DOI
- 1995, NeuroReport, 6, 1063, 10.1097/00001756-199505090-00028 · DOI · Paper page
- 10.1016/j.neulet.2006.11.040 · DOI
- 10.1073/pnas.0908953107 · DOI · Paper page
- 10.1016/j.biopsych.2010.05.030 · DOI · Paper page
- 2002, Journal of Neural Transmission, 241
- 2012, Hippocampus, 22, 335
- 10.1186/1742-4933-7-2 · DOI
- 10.3389/fnagi.2010.00036 · DOI · Paper page
- 10.1016/j.neuroscience.2010.02.050 · DOI · Paper page
- 10.1016/j.bbr.2010.12.030 · DOI · Paper page
- 2005, Cell Transplantation, 14, 21, 10.3727/000000005783983313 · DOI
- 10.1111/j.1471-4159.2010.06622.x · DOI · Paper page
- 10.1016/j.pnpbp.2008.10.006 · DOI
- 10.1002/ar.20969 · DOI
- 10.1016/j.jns.2010.08.029 · DOI
- 2000, Journal of Neuropathology and Experimental Neurology, 59, 1011, 10.1093/jnen/59.11.1011 · DOI · Paper page
- 10.1016/S0891-5849(02)00861-4 · DOI
- 2001, Journal of Neural Transmission, 223
- 10.1196/annals.1427.010 · DOI · Paper page
- 10.1136/bmj.39465.544028.AE · DOI · Paper page
- 10.1016/j.expneurol.2008.11.021 · DOI · Paper page
- 10.1038/35037739 · DOI · Paper page
- 10.1093/hmg/ddm049 · DOI
Cited by
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Dementia in Down syndrome: unique insights for Alzheimer disease research
Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383
Functional neuroanatomy of the central noradrenergic system
Szabadi, E. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113490326 · Cited by 335
Down syndrome and Alzheimer's disease: common pathways, common goals
Hartley, D., Blumenthal, T., Carrillo, M., DiPaolo, G., Esralew, L., Gardiner, K., Granholm, A.-C., Iqbal, K., Krams, M., Lemere, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.007 · Cited by 290
“[24] Lockrow JP, Fortress AM, Granholm AC.”
BackgroundSelf-citationChen, C., Jiang, P., Xue, H., Peterson, S. E., Tran, H. T., McCann, A. E., Parast, M. M., Li, S., Pleasure, D. E., Laurent, L. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms5430 · Cited by 219
Metadata
- Authors
- Lockrow, J. P., Fortress, A. M., & Granholm, A.-C. E.
- Venue
- Current Gerontology and Geriatrics Research
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-13
- ISSN
- 1687-7063 (ISSN-L)
- 1687-7071
- OpenAlex
- W2020657007
- Cited by
- 63
- References
- 28
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age-Related Neurodegeneration and Memory Loss in Down Syndrome. https://app.cochat.ai/papers/10.1155/2012/463909
- The paper
- Lockrow, J. P., Fortress, A. M., & Granholm, A.-C. E. (2012). Age-Related Neurodegeneration and Memory Loss in Down Syndrome. Current Gerontology and Geriatrics Research. https://doi.org/10.1155/2012/463909
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.